The effects of a single session of moderate intensity (65% VO(2)max) aerobic exercise expending 500 kcal of energy on serum lipid and lipoprotein-cholesterol concentrations and the electrophoretic characteristics of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particles were determined in 11 sedentary, eumenorrheic, premenopausal women immediately prior to, and 24 and 48 h following exercise. Repeated measures analysis of variance revealed significant reductions in triglyceride (25.0%), HDL-cholesterol (10.9%), and HDL(3)-cholesterol (11.9%) concentrations at 48 h post-exercise. Despite these changes in lipid and lipoprotein-cholesterol concentrations, no significant changes were observed in peak LDL or HDL particle sizes or in the distribution of cholesterol within the LDL and HDL subfractions. Accordingly, it appears that a single session of moderate intensity aerobic exercise expending 500 kcal (2,092 kJ) of energy promotes reductions in triglyceride, HDL-C, and HDL(3)-C concentrations without concomitantly affecting the electrophoretic characteristics of LDL and HDL particles in this sample of women.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00421-008-0770-2DOI Listing

Publication Analysis

Top Keywords

lipid lipoprotein-cholesterol
12
electrophoretic characteristics
12
aerobic exercise
12
ldl hdl
12
single session
8
session moderate
8
moderate intensity
8
exercise expending
8
expending 500
8
500 kcal
8

Similar Publications

Hormonal changes throughout a woman's life cycle significantly affect serum lipid levels. Alterations in the serum lipid profile can increase the risk of cardiovascular diseases (CVDs). Additionally, nutrition and dietary habits are crucial for managing dyslipidemia.

View Article and Find Full Text PDF

: Familial hypercholesterolemia (FH) is a monogenic dyslipidemia that leads to early cardiovascular events. Subclinical atherosclerosis refers to the formation of atheromatous plaques in arterial beds before any clinical events. In our study, we investigated the presence, extent, and independent predictors of subclinical atherosclerosis among patients diagnosed with FH.

View Article and Find Full Text PDF

This study assessed the proportion of secondary cardiovascular prevention patients who achieved low-density lipoprotein (LDL) cholesterol targets as per the 2019 ESC/EAS Dyslipidemia Guidelines. We also evaluated whether lipid-lowering therapies (LLTs) were adjusted in patients not meeting targets and analyzed the likelihood of these modifications achieving recommended levels. A multicenter, cross-sectional observational study retrospectively reviewed medical records of 1909 outpatients in 9 Italian cardiac rehabilitation/secondary prevention clinics from January 2023 to June 2024.

View Article and Find Full Text PDF

This study assessed the therapeutic effectiveness of a single-pill combination (SPC) of olmesartan/amlodipine plus rosuvastatin for blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) in patients with hypertension and dyslipidemia. Adult patients with hypertension and dyslipidemia who were decided to be treated with the study drug were eligible. The primary endpoint was the proportion of patients who achieved BP, LDL-C and both BP and LDL-C treatment goals at weeks 24-48.

View Article and Find Full Text PDF

Low-density lipoprotein cholesterol (LDL-C) is a well-established risk factor for cardiovascular disease, and it plays a causal role in the development of atherosclerosis. Genome-wide association studies (GWASs) have successfully identified hundreds of genetic variants associated with LDL-C. Most of these risk loci fall in non-coding regions of the genome, and it is unclear how these non-coding variants affect circulating lipid levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!